Trends in Biologics Manufacturing from Drug Substance to Fill/Finish
Summary: The biologics industry is growing rapidly with an estimated 40% of biopharmaceuticals in the industry pipeline. Consequently, pharmaceutical companies are strategically partnering with contract development and manufacturing organizations to help those companies meet the high demand of their biologics. With this rapid growth and partnership between companies, certain trends are emerging for biomanufacturing and fill/finish.